Post-pyloric Drug Administration in Enteral Nutrition
PDF
Cite
Share
Request
Review
P: 1-8
March 2022

Post-pyloric Drug Administration in Enteral Nutrition

J Turk Soc Intens Care 2022;20(1):1-8
1. Hacettepe Üniversitesi Eczacılık Fakültesi, Klinik Eczacılık Anabilim Dalı, Ankara, Türkiye
No information available.
No information available
Received Date: 15.02.2021
Accepted Date: 27.01.2022
Publish Date: 02.03.2022
PDF
Cite
Share
Request

ABSTRACT

Most of the patients who require enteral nutrition therapy also require concomitant medication administration. In this review, the appropriate medication administration through the post-pyloric feeding tube and related issues that should be considered by clinicians has been focused and accordingly appropriateness of some medication available in our country were listed. Before the drug administration via feeding tube, information such as length of the functional bowel, the inner diameter and length of the tube, the location of distal end of the feeding tube should be considered. The location of distal end of the feeding tube plays an important role for drug absorption due to differences in pH and osmolarity between stomach and jejunum. While a medication designed for oral use administered directly to the jejunum, its bioavailability, gastric complaints and malabsorption may alter, since the expected process (dissolution in stomach and absorption from small intestine) cannot be pursued. As a result, inappropriate medication administration in patients with post-pyloric feeding tube may lead to ineffectiveness, adverse reactions or toxicity of the medication. Therefore, to provide optimal pharmaceutical and nutritional treatment together, medications should be evaluated for appropriateness before administration via post-pyloric feeding tube by the multidisciplinary team, including clinical pharmacists.

Keywords: Clinical pharmacy, post-pyloric feeding, jejunum, medication administration via feeding tube

References

1
Cederholm T, Barazzoni R, Austin P, Ballmer P, Biolo G, Bischoff SC, et al. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr 2017;36:49-64.
2
Demirkan K, Ekincioglu A. The Importance of Pharmaceutical Dosage Forms in Administration via Enteral Feeding Tubes. Journal of The Turkish Society of Intensive Care 2016;14:1-8.
3
Williams NT. Medication administration through enteral feeding tubes. Am J Health Syst Pharm 2008;65:2347-57.
4
Magnuson BL, Clifford TM, Hoskins LA, Bernard AC. Enteral nutrition and drug administration, interactions, and complications. Nutr Clin Pract 2005;20:618-24.
5
Boullata JI. Drug administration through an enteral feeding tube. Am J Nurs 2009;109:34-42.
6
Belknap DC, Seifert CF, Petermann M. Administration of medications through enteral feeding catheters. Am J Crit Care 1997;6:382-92.
7
Bankhead R, Boullata J, Brantley S, Corkins M, Guenter P, Krenitsky J, et al. Enteral nutrition practice recommendations. JPEN J Parenter Enteral Nutr 2009;33:122-67.
8
Boullata JI, Carrera AL, Harvey L, Escuro AA, Hudson L, Mays A, et al. ASPEN Safe Practices for Enteral Nutrition Therapy [Formula: see text]. JPEN J Parenter Enteral Nutr 2017;41:15-103.
9
Morishita M, Peppas NA. Is the oral route possible for peptide and protein drug delivery? Drug Discov Today 2006;11:905-10.
10
Sharpe LA, Daily AM, Horava SD, Peppas NA. Therapeutic applications of hydrogels in oral drug delivery. Expert Opin Drug Deliv 2014;11:901-15.
11
Friend DR. Drug delivery to the small intestine. Curr Gastroenterol Rep 2004;6:371-6.
12
Boullata JI. Enteral Medication for the Tube-Fed Patient: Making This Route Safe and Effective. Nutr Clin Pract 2021;36:111-32.
13
Beckwith MC, Feddema SS, Barton RG, Graves C. A guide to drug therapy in patients with enteral feeding tubes: dosage form selection and administration methods. Hospital Pharmacy 2004;39:225-37.
14
Johnson T. Enteral nutrition. In: Shaw V, editor. Clinical Paediatric Dietetics. 5th ed. John Wiley & Sons Ltd; 2020. p. 52-63.
15
Scott R, Elwood T. GOSH guideline: Nasojejunal (NJ) and orojejunal (OJ) management. 2015.
16
Thomson FC, Naysmith MR, Lindsay A. Managing drug therapy in patients receiving enteral and parenteral nutrition. Pharm J 2000. Available from URL: https://pharmaceutical-journal.com/article/ld/managing-drug-therapy-in-patients-receiving-enteral-and-parenteral-nutrition. Accessed November 21, 2020.
17
Williams NT. Medication administration through enteral feeding tubes. Am J Health Syst Pharm 2008;65:2347-57.
18
Sacks GS. Drug-nutrient considerations in patients receiving parenteral and enteral nutrition. Pract Gastroenter 2004;19:39-48.
19
Ekincioğlu AB, Demirkan K. Clinical nutrition and drug interactions. Turkish Journal of Surgery 2013;29:177-86.
20
White R. Defining interactions. In: White R, Bradnam V (eds): Handbook of drug administration via enteral feeding tubes. London: British Pharmaceutical Nutrition Group and Pharmaceutical Press; 2007: p. 52-7.
21
McIntyre CM, Monk HM. Medication absorption considerations in patients with postpyloric enteral feeding tubes. Am J Health Syst Pharm 2014;71:549-56.
2024 ©️ Galenos Publishing House